Page last updated: 2024-08-26

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and cycloleucine

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with cycloleucine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Attwell, PJ; Bradford, HF; Croucher, MJ; Jane, DE; Kaura, S; Sigala, G; Watkins, JC1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and cycloleucine

ArticleYear
Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist.
    Brain research, 1995, Nov-06, Volume: 698, Issue:1-2

    Topics: Animals; Cycloleucine; Epilepsy; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Synaptosomes

1995
chemdatabank.com